Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from The impact of tacrolimus variability on first year renal function in kidney transplant recipients. Local targets link to admitted publications; unresolved targets remain external evidence.
A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation.
10.1111/ajt.16002 · 2020 · External reference
Clinical significance of tacrolimus intra-patient variability on kidney transplant outcomes according to pre-transplant immunological risk.
2021 · External reference
Factors influencing intrapatient variability of tacrolimus and its association with 1-year post-transplant outcomes in pediatric liver transplant recipients.
10.3389/fphar.2024.1473891 · 2024 · External reference
High tacrolimus intrapatient variability and subtherapeutic immunosuppression are associated with adverse kidney transplant outcomes.
10.1097/ftd.0000000000000955 · 2022 · External reference
Association of intrapatient variability of tacrolimus concentration with early deterioration of chronic histologic lesions in kidney transplantation.
10.1097/txd.0000000000000899 · 2019 · External reference
Correlation of renal function with intra-patient variability of tacrolimus concentration among recipients of renal transplants: a 10-year study.
10.21037/tau-24-564 · 2025 · External reference
High intrapatient tacrolimus variability is associated with worse outcomes in renal transplantation using a low-dose tacrolimus immunosuppressive regime.
10.1097/tp.0000000000001129 · 2017 · External reference
Patterns in tacrolimus variability and association with de novo donor-specific antibody formation in pediatric kidney transplant recipients.
10.2215/cjn.16421221 · 2022 · External reference
Tacrolimus variability score outperforms coefficient of variation in predicting clinical outcomes of living kidney transplantation.
10.1111/bcp.14876 · 2022 · External reference
Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management.
10.1016/j.trre.2015.01.002 · 2015 · External reference
Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence.
10.3389/fphar.2022.973564 · 2022 · External reference
Intrapatient tacrolimus variability is associated with medical nonadherence among pediatric kidney transplant recipients.
10.3389/frtra.2025.1572928 · 2025 · External reference
Tacrolimus intra-patient variability measures and its associations with allograft clinical outcomes in kidney transplantation.
10.1016/j.trre.2024.100842 · 2024 · External reference
Impact of tacrolimus intra-patient variability in adverse outcomes after organ transplantation.
10.5500/wjt.v13.i5.254 · 2023 · External reference
Etiologies and outcomes associated with tacrolimus levels out of a typical range that lead to high variability in kidney transplant recipients.
10.1097/ftd.0000000000000863 · 2021 · External reference
Intrapatient variability in tacrolimus trough levels over 2 years affects long-term allograft outcomes of kidney transplantation.
10.3389/fimmu.2021.746013 · 2021 · External reference
Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk.
10.1007/s00467-022-05426-3 · 2022 · External reference
A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients.
10.1111/cts.13206 · 2022 · External reference
The pre-transplant drop in panel-reactive antibodies titer evaluated using complement-dependent cytotoxicity (PRA-CDC) and the risk of early acute rejection in sensitized kidney transplant recipients.
10.3390/medicina54050066 · 2018 · External reference
Differences between very highly sensitized kidney transplant recipients as identified by machine learning consensus clustering.
10.3390/medicina59050977 · 2023 · External reference
Insight into the potential influence of inter-and intra-individual variability of tacrolimus exposure on graft function decline in three-year period following kidney transplantation.
10.31925/farmacia.2020.6.10 · 2020 · External reference
Impact of intra-patient variability of tacrolimus on allograft function and CD4 +/CD8 + ratio in kidney transplant recipients: a retrospective single-center study.
10.1007/s11096-024-01726-w · 2024 · External reference
Tacrolimus intrapatient variability on graft outcomes in adherent renal transplantation patients: a cross-sectional study.
2024 · External reference
Tacrolimus IPV group membership does not consistently track with electronically monitored or self-reported adherence in adolescent and young adult kidney transplant recipients.
10.1097/txd.0000000000001806 · 2025 · External reference
Increasing time in therapeutic range of tacrolimus in the first year predicts better outcomes in living-donor kidney transplantation.
10.3389/fimmu.2019.02912 · 2019 · External reference
Reduction of exposure to tacrolimus trough level variability is associated with better graft survival after kidney transplantation.
10.1007/s00228-019-02643-y · 2019 · External reference
A high intrapatient variability in tacrolimus exposure is associated with poor long‐term outcome of kidney transplantation.
10.1111/tri.12798 · 2016 · External reference
Tacrolimus intrapatient variability in BK virus nephropathy and chronic calcineurin toxicity in kidney transplantation.
10.4103/1319-2442.335446 · 2021 · External reference
MO999: intra-patient variability of tacrolimus in kidney transplant patients: an experience of a kidney disease specialist hospital.
10.1093/ndt/gfac088.001 · 2022 · External reference
The number of episodes of subtherapeutic tacrolimus blood level is independently associated with reduced kidney graft survival.
10.1111/ctr.15460 · 2024 · External reference
Lower time in therapeutic range relates to a worse kidney graft outcome.
10.1016/j.transproceed.2022.09.013 · 2022 · External reference
Early monitoring and subsequent gain of tacrolimus time-in-therapeutic range may improve clinical outcomes after living kidney transplantation.
10.1097/ftd.0000000000000881 · 2021 · External reference
Tacrolimus time in therapeutic range and long-term outcomes in heart transplant recipients.
10.1002/phar.2653 · 2022 · External reference
MO1013: what is the best measure of time in the therapeutic range of tacrolimus for kidney transplantation?
10.1093/ndt/gfac088.015 · 2022 · External reference
Benefits of living over deceased donor kidney transplantation in elderly recipients. a propensity score matched analysis of a Large European Registry Cohort.
10.3389/ti.2024.13452 · 2024 · External reference
Study of donors weight and sex correlation with recipients graft function in living related renal transplant.
10.1097/01.tp.0000700808.81606.2e · 2020 · External reference
The impact of living kidney donor glomerular filtration rate on graft survival.
10.3390/medicina61040580 · 2025 · External reference
Effects of delayed graft function on transplant outcomes: a meta-analysis.
10.1097/txd.0000000000001433 · 2023 · External reference
Does the timing of acute rejection matter with the graft outcome in kidney transplantation?
10.1016/j.krcp.2015.07.004 · 2015 · External reference